SPRO stock forecast
Our latest prediction for Spero Therapeutics, Inc.'s stock price was made on the July 17, 2018 when the stock price was at 11.70$.
In the short term (2weeks), SPRO's stock price should outperform the market by 4.90%. During that period the price should oscillate between -11.00% and +18.28%.
In the medium term (3months), SPRO's stock price should outperform the market by 2.66%. During that period the price should oscillate between -23.55% and +40.53%.Get email alerts
About Spero Therapeutics, Inc.
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant, or MDR, bacterial infections. Its pipeline product candidates include SPR994, SPR741, and SPR206. The company was founded by Ankit A. Mahadevia and Laurence Rahme in April 2013 and is headquartered in Cambridge, MA.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -2.52$ per share.
The book value per share is 3.59$
Three months stock forecastJuly 17, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|